Oxaliplatin

Colorectal Cancer Treatment

Oxaliplatin is a platinum-based chemotherapy drug used to treat cancer of the colon or rectum. It is typically prescribed for the following indications:

• Advanced Colorectal Cancer: It is used to treat cancer that has spread to other parts of the body (metastatic cancer).
• Adjuvant Treatment: It is used to treat stage III colon cancer in patients who have already had surgery to remove the primary tumor. In this setting, the medication is used to help prevent the cancer from coming back.

Combination Therapy

Oxaliplatin is usually administered as part of a combination chemotherapy regimen rather than on its own. It is most commonly given in cycles alongside other medications, such as 5-fluorouracil and leucovorin. This combination is often used to increase the effectiveness of the treatment against cancer cells.

Mechanism of Action

Oxaliplatin belongs to a group of medicines called platinum-containing antineoplastic agents. It works by targeting the genetic material, or DNA, inside cells.

When oxaliplatin enters a cancer cell, it undergoes a chemical change that allows it to bind to the cell's DNA. This binding creates cross-links, which are structural blocks that prevent the DNA strands from separating or being copied correctly. Because cells must copy their DNA to divide and create new cells, these cross-links effectively stop the cancer from spreading.

Key aspects of how oxaliplatin works include:

• DNA Damage: By forming bridges between DNA strands, the drug prevents the cell from reading its genetic instructions.
• Inhibition of Replication: The cell becomes unable to replicate its DNA, which is a necessary step for cell division.
• Cell Death: When a cell's DNA is too damaged to be repaired, the cell receives a signal to destroy itself, a process known as apoptosis.

While oxaliplatin affects both healthy and cancerous cells, it is particularly effective against cancer cells because they typically divide much faster than most normal cells in the body.

Common Side Effects

• Nausea and vomiting
• Diarrhea or constipation
• Fatigue and general weakness
• Mouth sores or inflammation
• Loss of appetite and weight loss
• Stomach pain
• Changes in taste

Nerve and Cold Sensitivity

A frequent side effect of oxaliplatin is peripheral neuropathy, which causes numbness, tingling, or burning in the hands and feet. Many patients also experience acute sensitivity to cold. This can lead to discomfort or pain when touching cold items, consuming cold food or drinks, or breathing cold air.

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following:

• Signs of an allergic reaction, including rash, hives, or swelling of the face and throat
• Symptoms of low blood cell counts, such as fever, chills, unusual bruising, or pale skin
• Chest pain, shortness of breath, or a fast or irregular heartbeat
• Sudden vision changes or hearing loss
• Severe or persistent diarrhea and vomiting
• Signs of liver issues, such as dark urine or yellowing of the eyes and skin

Severe Allergic Reactions

Oxaliplatin can cause life-threatening allergic reactions (anaphylaxis). These reactions can occur at any time during an infusion, even if previous treatments were tolerated. Immediate medical attention is required if symptoms like rash, hives, swelling, or difficulty breathing occur.

Nerve Damage (Neuropathy)

Nerve-related issues are common and may occur in two forms:

• Acute Neuropathy: This often occurs during or shortly after the infusion and is frequently triggered by exposure to cold temperatures or cold objects. It may cause tingling, numbness, or cramping in the hands, feet, or throat.
• Cumulative Neuropathy: Long-term use can lead to persistent numbness or tingling that may interfere with daily activities like walking or picking up objects.

Organ and System Risks

Liver and Lung Toxicity

This medication may cause liver damage, including conditions that affect the blood vessels in the liver. It has also been linked to serious lung conditions, such as interstitial lung disease or pulmonary fibrosis, which can cause shortness of breath or a dry cough.

Heart Rhythm Changes

Oxaliplatin may affect the electrical activity of the heart (QT prolongation), which can lead to serious heart rhythm disturbances. Monitoring of electrolytes and heart function may be necessary.

Blood Cell Counts

Treatment can significantly lower white blood cell and platelet counts, increasing the risk of infections or unusual bleeding and bruising.

Other Serious Conditions

Rare but serious complications include Posterior Reversible Encephalopathy Syndrome (PRES), a brain disorder that causes headache, confusion, or vision changes, and rhabdomyolysis, which involves the breakdown of muscle tissue.

Pregnancy and Reproduction

Oxaliplatin can cause fetal harm. Effective contraception is recommended for both men and women during treatment and for a specific period afterward. Breastfeeding is generally not recommended during therapy.

Pregnancy

Oxaliplatin may cause fetal harm if used during pregnancy. Based on its mechanism of action and findings from animal studies, the drug can interfere with fetal development. Patients should notify their healthcare provider immediately if they become pregnant during treatment.

Contraception Requirements

Because of the risks to a pregnancy, healthcare providers typically recommend the following precautions:

• Females: Use effective contraception during treatment and for 9 months after the final dose.
• Males: Use effective contraception when with a partner of reproductive potential during treatment and for 6 months after the final dose.

Breastfeeding

There is no data on the presence of oxaliplatin in human milk or its effects on milk production. However, because of the potential for serious adverse reactions in a breastfed child, breastfeeding is not recommended during treatment and for 3 months following the last dose. Patients should consult with their doctor to determine the safest way to feed their infant during this time.

Available Forms

Oxaliplatin is available in the following forms for intravenous administration:

• Injection: A clear, colorless solution provided in vials.
• Lyophilized Powder: A sterile powder that must be reconstituted and further diluted before use.

This medication is administered only by infusion into a vein and is not available in oral forms such as tablets or capsules.

FDA Approval and Indications

Oxaliplatin is an FDA-approved platinum-based chemotherapy drug. It is indicated for use in combination with 5-fluorouracil and leucovorin for the following conditions:

• Adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
• Treatment of advanced colorectal cancer.

Boxed Warning

The FDA labeling for oxaliplatin includes a boxed warning regarding severe allergic reactions, including anaphylaxis. These reactions have been reported in patients receiving oxaliplatin and can occur at any time during the infusion. Healthcare providers are advised to monitor patients closely and have emergency equipment available to treat life-threatening allergic responses.

Regulatory Status

Oxaliplatin is a prescription medication administered intravenously by healthcare professionals. It is available as a generic medication. There are no specific Risk Evaluation and Mitigation Strategy (REMS) programs currently required for this drug beyond the standard safety protocols for chemotherapy administration.

Factors Influencing Cost

Oxaliplatin is an intravenous medication administered by healthcare professionals in a hospital or infusion center. Because it is not a drug you purchase at a retail pharmacy, the total cost often includes the price of the medication itself plus fees for the clinical staff and facility services. The dosage is typically based on your body surface area, which also affects the final price.

Generic Availability

Oxaliplatin is available as a generic drug. Generic medications are generally less expensive than brand-name versions while providing the same therapeutic effect. Choosing the generic form may help reduce the overall cost of treatment.

Insurance and Financial Assistance

Most health insurance plans, including Medicare and private insurance, cover oxaliplatin when it is used for FDA-approved indications. However, out-of-pocket costs such as copayments or deductibles can vary significantly between plans. Some patients may be eligible for financial assistance programs through non-profit organizations or manufacturer-sponsored programs to help manage these expenses.

It is recommended to contact your insurance provider and the billing department of your treatment facility to obtain a specific estimate of your costs before starting treatment.